AstraZeneca Proclaims Promising Long-Acting COVID-19 Antibody

Results For Evusheld Upgrade Due In H2 2023

 
• By Kevin Grogan
  
Mark Esser
Mark Esser • Source: AstraZeneca

More from COVID-19

More from Scrip